Primary Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs): Contexts and Comparisons in EGFR-Mutated Lung Cancer
The discovery of the efficacy of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (<i>EGFR</i>)-mutated non-small-cell lung cancer (NSCLC) patients has revolutionized lung cancer therapy. Although almost all responders acquire drug resistance within a few years, many...
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
MDPI AG
2023-12-01
|
| coleção: | Journal of Respiration |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2673-527X/3/4/21 |